
Timing of access to drugs and advanced therapies (ATMP) for ultra-rare diseases
On Tuesday 29 November 2022, Ginevra Mastroianni, Institutional and Regulatory Affairs Specialist at Pharma Value, presented at the 8th National Congress of ISPOR Italy - Rome Chapter a